Anna Schwendeman

8.0k total citations · 3 hit papers
113 papers, 5.9k citations indexed

About

Anna Schwendeman is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Anna Schwendeman has authored 113 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 33 papers in Immunology and 29 papers in Surgery. Recurrent topics in Anna Schwendeman's work include Cholesterol and Lipid Metabolism (15 papers), Advanced Drug Delivery Systems (14 papers) and Immunotherapy and Immune Responses (13 papers). Anna Schwendeman is often cited by papers focused on Cholesterol and Lipid Metabolism (15 papers), Advanced Drug Delivery Systems (14 papers) and Immunotherapy and Immune Responses (13 papers). Anna Schwendeman collaborates with scholars based in United States, China and Argentina. Anna Schwendeman's co-authors include James J. Moon, Rui Kuai, Lukasz J. Ochyl, Keith S. Bahjat, Emily E. Morin, Sejin Son, Jutaek Nam, Wenmin Yuan, Minzhi Yu and Hongliang He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Anna Schwendeman

109 papers receiving 5.8k citations

Hit Papers

Designer vaccine nanodiscs for personalized cancer immuno... 2016 2026 2019 2022 2016 2018 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Schwendeman United States 34 2.2k 2.2k 1.9k 1.4k 956 113 5.9k
Jee‐Heon Jeong South Korea 43 2.1k 1.0× 1.7k 0.8× 826 0.4× 1.6k 1.1× 748 0.8× 180 5.5k
Hao Cheng United States 39 2.2k 1.0× 1.8k 0.8× 672 0.4× 1.4k 1.0× 542 0.6× 92 5.0k
Josbert M. Metselaar Netherlands 42 1.3k 0.6× 2.0k 0.9× 1.0k 0.6× 1.9k 1.3× 548 0.6× 101 5.7k
Changyang Gong China 47 2.1k 1.0× 2.5k 1.2× 1.4k 0.7× 2.8k 1.9× 957 1.0× 159 7.9k
Jie Gao China 43 1.8k 0.8× 2.9k 1.3× 689 0.4× 1.7k 1.2× 882 0.9× 238 6.4k
In‐San Kim South Korea 50 1.2k 0.6× 4.6k 2.1× 1.5k 0.8× 1.1k 0.7× 1.0k 1.1× 166 7.7k
Hidetaka Akita Japan 52 1.7k 0.8× 7.6k 3.5× 1.1k 0.6× 2.5k 1.7× 1.3k 1.4× 245 11.1k
Ran Mo China 41 3.6k 1.7× 3.5k 1.6× 752 0.4× 3.3k 2.3× 685 0.7× 110 7.6k
Robbert J. Kok Netherlands 44 1.2k 0.6× 3.0k 1.4× 614 0.3× 1.7k 1.2× 658 0.7× 136 6.4k
Timo L.M. ten Hagen Netherlands 49 3.1k 1.4× 3.6k 1.7× 1.4k 0.8× 2.7k 1.8× 1.8k 1.9× 212 8.8k

Countries citing papers authored by Anna Schwendeman

Since Specialization
Citations

This map shows the geographic impact of Anna Schwendeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schwendeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schwendeman more than expected).

Fields of papers citing papers by Anna Schwendeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Schwendeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schwendeman. The network helps show where Anna Schwendeman may publish in the future.

Co-authorship network of co-authors of Anna Schwendeman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Schwendeman. A scholar is included among the top collaborators of Anna Schwendeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Schwendeman. Anna Schwendeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yaozhong, Minzhi Yu, Huilun Wang, et al.. (2025). Restoring Vascular Smooth Muscle Cell Mitochondrial Function Attenuates Abdominal Aortic Aneurysm in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 45(4). 523–540.
2.
Ackermann, Rose, Minzhi Yu, Xinye Wang, et al.. (2024). Reverse engineering of Onivyde® – Irinotecan liposome injection. International Journal of Pharmaceutics. 669. 125000–125000. 6 indexed citations
3.
Schwendeman, Anna, et al.. (2024). Development and optimization of an in vitro release assay for evaluation of liposomal irinotecan formulation. International Journal of Pharmaceutics. 667(Pt A). 124854–124854. 3 indexed citations
4.
Banerjee, Kaushik, Anzar Mujeeb, Sophia Lee, et al.. (2024). Controlled Delivery of Paclitaxel via Stable Synthetic Protein Nanoparticles. Advanced Therapeutics. 7(11). 7 indexed citations
5.
Babiskin, Andrew, Fang Wu, Ming‐Liang Tan, et al.. (2023). Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview. CPT Pharmacometrics & Systems Pharmacology. 12(5). 619–623. 10 indexed citations
6.
Dubey, Nileshkumar, Juliana Silva Ribeiro, Zhaocheng Zhang, et al.. (2023). Gelatin methacryloyl hydrogel as an injectable scaffold with multi-therapeutic effects to promote antimicrobial disinfection and angiogenesis for regenerative endodontics. Journal of Materials Chemistry B. 11(17). 3823–3835. 20 indexed citations
7.
Gong, Yuqing, Miyoung Yoon, Hao Zhu, et al.. (2023). Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: Summary of workshop. CPT Pharmacometrics & Systems Pharmacology. 12(5). 624–630. 7 indexed citations
8.
Aizenshtadt, Aleksandra, Minzhi Yu, Anna Schwendeman, et al.. (2023). Quantitative chemometric phenotyping of three-dimensional liver organoids by Raman spectral imaging. Cell Reports Methods. 3(4). 100440–100440. 18 indexed citations
9.
Schultz, Mark L., et al.. (2023). Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiency. Nanomedicine Nanotechnology Biology and Medicine. 53. 102705–102705. 1 indexed citations
10.
Hong, Justin K. Y., Yayuan Liu, Jie Tang, et al.. (2022). Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid). Nature Communications. 13(1). 3282–3282. 36 indexed citations
11.
Mei, Ling, Minzhi Yu, Yayuan Liu, et al.. (2022). Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration. Nanomedicine Nanotechnology Biology and Medicine. 44. 102571–102571. 15 indexed citations
12.
Scheetz, Lindsay, Minzhi Yu, Dan Li, et al.. (2020). Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma. International Journal of Molecular Sciences. 21(5). 1777–1777. 29 indexed citations
13.
Garcia-Fabiani, María Belén, Andrea Comba, Marianela Candolfi, et al.. (2020). Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development. Expert Opinion on Investigational Drugs. 29(7). 659–684. 17 indexed citations
14.
Scheetz, Lindsay, Padma Kadiyala, Xiaoqi Sun, et al.. (2020). Synthetic High-density Lipoprotein Nanodiscs for Personalized Immunotherapy Against Gliomas. Clinical Cancer Research. 26(16). 4369–4380. 64 indexed citations
15.
Patel, Hiren, Bei Ding, Lei Shen, et al.. (2019). Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly. Dove Medical Press (Taylor and Francis Group). 1 indexed citations
16.
Scheetz, Lindsay, Kyong Soo Park, Qiao Li, et al.. (2019). Engineering patient-specific cancer immunotherapies. Nature Biomedical Engineering. 3(10). 768–782. 166 indexed citations
17.
Wang, Ton, Chitra Subramanian, Minzhi Yu, et al.. (2019). Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer. Surgery. 166(6). 1168–1175. 10 indexed citations
18.
Manthei, Kelly A., Shyh‐Ming Yang, Bolormaa Baljinnyam, et al.. (2018). Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol. eLife. 7. 31 indexed citations
19.
Doty, Amy C., Keiji Hirota, Karl Olsen, et al.. (2016). Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres. Biomaterials. 109. 88–96. 25 indexed citations
20.
Keyserling, Constance, Thomas L. Hunt, Robert A. Scott, et al.. (2011). Abstract 15525: CER-001, a Synthetic HDL-Mimetic, Safely Mobilizes Cholesterol in Healthy Dyslipidemic Volunteers. Circulation. 124. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026